Avinger, Inc. (AVGR)
NASDAQ: AVGR · IEX Real-Time Price · USD
1.790
+0.060 (3.47%)
At close: Jul 2, 2024, 3:57 PM
1.740
-0.050 (-2.79%)
After-hours: Jul 2, 2024, 4:36 PM EDT
Avinger Revenue
Avinger had revenue of $7.62M in the twelve months ending March 31, 2024, down -7.86% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.86M, a -1.54% decrease year-over-year. In the year 2023, Avinger had annual revenue of $7.65M, a decrease of -7.51%.
Revenue (ttm)
$7.62M
Revenue Growth
-7.86%
P/S Ratio
0.46
Revenue / Employee
$112,103
Employees
68
Market Cap
3.54M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.65M | -621.00K | -7.51% |
Dec 31, 2022 | 8.27M | -1.86M | -18.33% |
Dec 31, 2021 | 10.13M | 1.37M | 15.63% |
Dec 31, 2020 | 8.76M | -370.00K | -4.05% |
Dec 31, 2019 | 9.13M | 1.22M | 15.36% |
Dec 31, 2018 | 7.92M | -2.02M | -20.32% |
Dec 31, 2017 | 9.93M | -9.28M | -48.30% |
Dec 31, 2016 | 19.21M | 8.50M | 79.35% |
Dec 31, 2015 | 10.71M | -500.00K | -4.46% |
Dec 31, 2014 | 11.21M | -1.75M | -13.51% |
Dec 31, 2013 | 12.96M | 4.40M | 51.45% |
Dec 31, 2012 | 8.56M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Xylo Technologies | 91.72M |
OpGen | 3.42M |
Assure Holdings | 1.63M |
Lipella Pharmaceuticals | 477.45K |
Heart Test Laboratories | 18.60K |
AVGR News
- 15 days ago - Avinger Announces Closing of up to $24 Million Public Offering - Accesswire
- 18 days ago - Avinger Announces Pricing of up to $24 Million Public Offering - Accesswire
- 27 days ago - Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business - Accesswire
- 6 weeks ago - Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity - Accesswire
- 6 weeks ago - Avinger Reports First Quarter 2024 Results - Accesswire
- 2 months ago - Avinger to Announce First Quarter 2024 Results on May 15, 2024 - Accesswire
- 3 months ago - Avinger Reports Fourth Quarter and Full Year 2023 Results - Accesswire
- 4 months ago - Avinger to Announce Full Year 2023 Results on March 20, 2024 - Accesswire